J.M. Forbes & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-122,776
Closed -$9.85M 107
2018
Q1
$9.85M Buy
122,776
+1,710
+1% +$141K 2.29% 15
2017
Q4
$9.78M Sell
121,066
-1,627
-1% -$130K 2.26% 14
2017
Q3
$9.54M Sell
122,693
-1,766
-1% -$147K 2.38% 18
2017
Q2
$11M Sell
124,459
-595
-0.5% -$50.2K 2.81% 10
2017
Q1
$10.1M Buy
125,054
+116
+0.1% +$9.06K 2.63% 13
2016
Q4
$8.9M Sell
124,938
-204
-0.2% -$16K 2.45% 17
2016
Q3
$10.8M Sell
125,142
-1,084
-0.9% -$94.5K 2.95% 7
2016
Q2
$11M Buy
126,226
+41,603
+49% +$3.36M 3.03% 6
2016
Q1
$6.35M Buy
84,623
+2,068
+3% +$156K 1.81% 29
2015
Q4
$6.35M Sell
82,555
-505
-0.6% -$38K 1.7% 30
2015
Q3
$5.56M Buy
83,060
+42,045
+103% +$3.1M 1.58% 31
2015
Q2
$3.04M Sell
41,015
-905
-2% -$69.1K 0.82% 44
2015
Q1
$3.27M Buy
+41,920
New +$3.18M 0.87% 44

Other funds holding MDT

J.M. Forbes & Co's MDT Position: Q2 2018 in Review

J.M. Forbes & Co sold out of Medtronic (MDT) in Q2 2018, closing a stake of 122,776 shares — an estimated $9.85M sold.

J.M. Forbes & Co first reported a position in MDT in Q1 2015 and held it in 13 quarters. The position peaked at $11M in Q2 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

  • J.M. Forbes & Co reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
  • J.M. Forbes & Co sold 122,776 Medtronic shares in Q2 2018, an estimated $9.85M.
  • J.M. Forbes & Co first reported a position in Medtronic in Q1 2015 and held it in 13 quarters.
  • J.M. Forbes & Co's Medtronic position peaked at $11M in Q2 2017.
  • 1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on J.M. Forbes & Co's 13F filing for Q2 2018, filed 10 Aug 2018.